CONSUMER ALERT: Ranitidine, the heartburn drug found in brand-name Zantac and generic versions, may be prone to breaking down into a cancer-causing substance, the FDA warns.
Canada has asked all drugmakers to stop distribution there, until they can prove their products don’t contain it.
. Now they’ve found a different one, NDMA, in ranitidine. It appeared in every batch they tested, from every manufacturer, and often at astonishing levels. The FDA’s permissible daily intake limit is 96 nanograms. Valisure said it followed an established testing protocol and found quantities in excess of 2 million nanograms per tablet.
Light pointed to research on ranitidine going back to the 1980s, and as recent as 2016. The pharmacy’s petition asks the FDA to recall all ranitidine products, including brand-name Zantac.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Labour on collision course with big pharma over drugsThere is a delicate balance to be struck between private profit and public good on drug research.
Baca lebih lajut »
Soulja Boy's Gained 50 lbs. Since Doing Time, Quit Drugs and AlcoholSoulja Boy's new drip has a lot more weight behind it ... 50 lbs. to be exact.
Baca lebih lajut »
Cancer Risks Spur Calls to Replace Ethylene OxideThe current outcry from communities that have been exposed to the carcinogen ethylene oxide has federal regulators and device makers seriously rethinking a question that’s been hanging over the sterilization industry for decades: Can ethylene oxide be replaced?
Baca lebih lajut »
FDA announces expanded recall of widely-used blood pressure drugFDA is again expanding its recall of widely prescribed blood pressure drugs due to contamination with a cancer-linked chemical. - TODAYShow
Baca lebih lajut »